(Press-News.org) HOUSTON and BOSTON, JANUARY 7, 2026 ― The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites SOPHiA GENETICS’ AI-powered analytics with MD Anderson’s clinical and scientific expertise to accelerate data-driven cancer care through new tools that can accurately analyze, interpret and translate diagnostic results into clinical practice.
As part of the collaboration, MD Anderson and SOPHiA GENETICS are launching a series of research and development programs and co-developing an advanced next-generation sequencing oncology test. Built on the advanced AI algorithms of the SOPHiA DDM™ Platform, the new co-developed test aims to translate complex multimodal data into actionable insights with greater speed and scale. MD Anderson researchers will tap SOPHiA GENETICS’ AI technologies to create bioinformatics pipelines that enable clinicians to rapidly interpret complex RNA-sequencing data to guide diagnosis and treatment for patients with cancer.
“Cancer research has evolved rapidly, and we have more health data available than ever before. Our collaboration with SOPHiA GENETICS reflects how our lab is evolving and integrating advanced analytics and AI to better interpret complex molecular information,” said Donna Hansel, M.D., Ph.D., division head of Pathology and Laboratory Medicine at MD Anderson. “This collaboration will expand our ability to translate high-dimensional data into insights that can meaningfully advance research and precision oncology.”
In addition, MD Anderson and SOPHiA GENETICS will jointly launch a series of research and development programs to explore new ways to characterize tumor evolution in real time, to strengthen the reliability and reproducibility of complex genomic testing, and to enhance the ability to identify optimal clinical trials or research avenues for individual patients. This multi-layered program is designed to fuel next-generation scientific discovery, empowering clinicians and researchers with tools to better understand the dynamic nature of cancer. The collaborative work at MD Anderson will be led by Shashikant Kulkarni, Ph.D., deputy division head for Molecular Pathology, and J. Bryan, M.D., assistant professor, both in the Division of Pathology and Laboratory Medicine.
“This collaboration with MD Anderson amplifies our shared ambition to push the boundaries of what is possible in cancer research,” said Philippe Menu, M.D., Ph.D., chief product officer and chief medical officer at SOPHiA GENETICS. “With SOPHiA DDM™ as a unifying analytical layer, we are enabling new discoveries, accelerating breakthroughs in precision oncology and, most importantly, enabling patients around the globe to benefit from these innovations by bringing leading technologies to all geographies quickly and at scale.”
- 30 -
END
MD Anderson and SOPHiA GENETICS announce strategic collaboration to accelerate AI-driven precision oncology
2026-01-07
ELSE PRESS RELEASES FROM THIS DATE:
Oil residues can travel over 5,000 miles on ocean debris, study finds
2026-01-07
When oily plastic and glass, as well as rubber, washed onto Florida beaches in 2020, a community group shared the mystery online, attracting scientists’ attention. Working together, they linked the black residue-coated debris to a 2019 oil slick along Brazil’s coastline. Using ocean current models and chemical analysis, the team explains in ACS’ Environmental Science & Technology how some of the oily material managed to travel over 5,200 miles (8,500 kilometers) by clinging to debris.
“The research findings of our study would not have been possible without the dedication of the Friends of Palm Beach,” says Bryan James, lead author ...
Korea University researchers discover that cholesterol-lowering drug can overcome chemotherapy resistance in triple-negative breast cancer
2026-01-07
Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and HER2 receptors and thus relying primarily on cytotoxic chemotherapy. Despite initial responsiveness, many patients experience rapid relapse driven by cancer stem-like cells that survive chemotherapy and seed metastasis.
Addressing this unmet need, researchers led by Professor Jae Hong Seo from Korea University have discovered that pitavastatin, a widely prescribed cholesterol-lowering drug, can directly inhibit the anti-apoptotic protein Mcl-1, a key driver ...
Ushikuvirus: A newly discovered giant virus may offer clues to the origin of life
2026-01-07
The origin of life on Earth becomes even more fascinating and complex as we peer into the mysterious world of viruses. Said to have existed since living cells first appeared, these microscopic entities differ greatly from other forms of life. Composed of only genetic material, they lack the ability to synthesize proteins, which are essential for carrying out cellular activity and, ultimately, for life by itself.
As a result, scientists have long sought to unravel virus origins, how they evolve, and how they fit into the conventional tree of life. Professor Masaharu Takemura from ...
Boosting the cell’s own cleanup
2026-01-07
Cells have a remarkable housekeeping system: proteins that are no longer needed, defective, or potentially harmful are labeled with a molecular “tag” and dismantled in the cellular recycling machinery. This process, known as the ubiquitin-proteasome system, is crucial for health and survival. Now, an international team of scientists led by CeMM, AITHYRA and the Max Planck Institute of Molecular Physiology in Dortmund has identified a new class of small molecules that harness this natural system to accelerate the removal of an immune-modulating enzyme called IDO1. The findings, published in Nature Chemistry (DOI: 10.1038/s41557-025-02021-5), introduce a new concept in ...
Movement matters: Light activity led to better survival in diabetes, heart, kidney disease
2026-01-07
Research Highlights:
Light physical activity was associated with lower risk of death for adults in stages 2, 3 and 4 of cardiovascular-kidney-metabolic (CKM) syndrome, a health condition that includes heart disease, kidney disease, diabetes and obesity.
A one hour increase in light physical activity each day was associated with a 14% to 20% lower risk of death.
The association between light physical activity and lower risk of death was most pronounced for people with advanced CKM syndrome.
Embargoed until 4 a.m. CT/5 a.m. ET Wednesday, January 7, 2026
DALLAS, ...
Method developed to identify best treatment combinations for glioblastoma based on unique cellular targets
2026-01-07
WASHINGTON – Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for treating glioblastoma, a lethal brain tumor. This approach enabled them to predict more effective treatment combinations to fight the disease on an individualized basis. This laboratory and computational research effort was led by scientists at Georgetown’s Lombardi Comprehensive Cancer Center.
“The cellular targets we identified could be key to effectively fighting a disease that has seen only one new targeted drug approved in the last two decades,” says Nagi G. Ayad, PhD, senior author, associate director for translational ...
Self-guided behavioral app helps children with epilepsy sleep earlier
2026-01-07
An evidence-based web-app helped children with epilepsy to fall asleep on average 16.5 minutes earlier.
A new UK-wide clinical trial led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has evaluated a self-guided behavioural sleep programme for the parents of children with epilepsy.
The programme, which is funded by the National Institute for Health and Care Research, is called COSI (CASTLE Online Sleep Intervention) and consists of online videos and written guides based on clinically informed sleep intervention behavioural techniques.
“Sleep problems affect more than 80% ...
Higher consumption of food preservatives is associated with an increased risk of type 2 diabetes
2026-01-07
Higher consumption of food preservatives, widely used in industrially processed foods and beverages to extend their shelf life, has been linked to an increased risk of type 2 diabetes. These findings are the result of work carried out by researchers from Inserm, INRAE, Sorbonne Paris Nord University, Paris Cité University and Cnam, within the Nutritional Epidemiology Research Team (CRESS-EREN). They are based on health and dietary data from more than 100,000 adults participating in the NutriNet-Santé cohort study, and ...
NTU Singapore-led team captures first-ever ‘twitch’ of the eye’s night-vision cells as they detect light, paving the way for earlier detection of blindness-causing diseases
2026-01-07
For the first time, an international research team led by Nanyang Technological University, Singapore (NTU Singapore) has recorded a tiny mechanical “twitch” in living human and rodent eyes at the exact moment a rod photoreceptor detects light.
The research breakthrough could provide a new, non-invasive way to assess retinal health and enable earlier diagnosis of blinding eye diseases, according to the research team, which involves multiple institutions including the University of Washington (UW), Singapore Eye Research Institute (SERI), and Duke-NUS Medical School.
Rod photoreceptors ...
Global aviation emissions could be halved through maximising efficiency gains, new study shows
2026-01-07
A new study co-led by the University of Oxford has found that global aviation emissions could be reduced by 50-75% through combining three strategies to boost efficiency: flying only the most fuel-efficient aircraft, switching to all-economy layouts, and increasing passenger loads. Crucially, the study shows that around a 11% reduction in global aviation emissions is achievable immediately, by using the most efficient aircraft that airlines already have more strategically on routes they already fly.
Published today (7 January) in Nature Communications Earth ...